文献速递关节外科创伤骨科

围手术期重复剂量地塞米松可有效减轻全髋关节置换术后疼痛、阿片需求、下地时间及住院时间

A Repeat Dose of Perioperative Dexamethasone Can Effectively Reduce Pain, Opioid Requirement, Time to Ambulation, and In-Hospital Stay After Total Hip Arthroplasty: A Prospective Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2021-08-27

该前瞻性随机对照试验比较单次与两次围手术期静脉地塞米松(8 mg)对单侧初次全髋关节置换术(THA)患者术后疼痛和曲马多需求的影响。结果显示,术后8小时追加一剂地塞米松可显著降低术后16和24小时疼痛评分、曲马多消耗量及术后恶心呕吐发生率,并提高术后第0天下地率和术后第1天出院率。

要点

  • 术后8小时追加8 mg地塞米松可显著降低THA术后16和24小时疼痛评分。
  • 两次地塞米松组曲马多消耗量及术后恶心呕吐发生率显著低于单次组。
  • 两次地塞米松组术后第0天下地率和第1天出院率显著高于单次组。

核心结论

  • 术后8小时追加一剂地塞米松可显著减轻初次THA术后疼痛、减少曲马多消耗、缩短下地时间和住院时间。

研究设计与样本

  • 前瞻性随机对照试验,单侧初次THA患者随机分为单次地塞米松组(麻醉诱导时8 mg,54例)和两次地塞米松组(术后8小时追加8 mg,61例)。

主要发现

  • 单次组术后16小时疼痛评分4(IQR 3-5)vs 两次组2(IQR 1-3),P<.001;术后24小时2.5(IQR 2-3)vs 1(IQR 0-1),P<.001。
  • 单次组曲马多消耗量50(IQR 50-100)vs 两次组0(IQR 0-50),P=.01。
  • 单次组术后恶心呕吐18例(33.3%)vs 两次组5例(8.2%),P=.001。

关键数值与推荐

  • 地塞米松剂量为8 mg静脉注射,单次组在麻醉诱导时给药,两次组在术后8小时追加一剂。
  • 两组年龄(均值66±13岁)、体重指数(均值29±5)、性别(女性60%)及糖尿病史相似(P>.05)。

临床怎么用

  • 对于初次THA患者,可考虑在麻醉诱导时给予8 mg地塞米松,并在术后8小时追加8 mg,以改善镇痛、减少阿片需求、促进早期下地和缩短住院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ideal dose of intravenous glucocorticoids to control pain in total hip arthroplasty (THA) remains unclear. This randomized controlled trial compared postoperative pain and tramadol requirement in patients undergoing unilateral primary THA who received one versus two perioperative doses of dexamethasone. METHODS: Patients consented to undergo blinded, simple randomization to either one (at anesthetic induction [1D-group]: 54 patients) or two (with an additional dose 8 hours after surgery [2D-group]: 61 patients) perioperative doses of 8-mg intravenous dexamethasone. Pain was evaluated with visual analog scale at 8, 16, and 24 hours postoperatively and with tramadol requirement. The secondary outcomes included postoperative nausea and vomiting, time to ambulation, and length of stay. RESULTS: Age (mean, 66 ± 13 years), body mass index (mean, 29 ± 5), gender (60% female), and history of diabetes were similar between groups (P >.05). Pain was higher at 16 (4 [interquartile range {IQR} 3-5] vs 2 [IQR 1-3]; P <.001) and 24 (2.5 [IQR 2-3] vs 1 [IQR 0-1] P <.001) hours postoperatively in the 1D-group patients. 1D-group patients had significantly more tramadol consumption (50 [IQR 50-100] vs 0 [IQR 0-50]; P = .01), as well as postoperative nausea and vomiting (18 [33.3%] vs 5 [8.2%]; P = .001). Fifty-five (90%) patients in the 2D-group and 32 (59%) in the 1D-group ambulated on postoperative day 0 (P = .0002). Fifty-eight (95%) patients in the 2D-group and 37 (68%) in the 1D-group were discharged on postoperative day 1 (P = .0002). CONCLUSION: An additional dose of dexamethasone at 8 hours postoperatively significantly reduced pain, tramadol consumption, time to ambulation, and length of stay after primary THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lucero CM, García-Mansilla A, Zanotti G, et al. A Repeat Dose of Perioperative Dexamethasone Can Effectively Reduce Pain, Opioid Requirement, Time to Ambulation, and In-Hospital Stay After Total Hip Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty. 2021. PMID: 34538546. doi:10.1016/j.arth.2021.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。